Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Pantheris™ Commercial Launch Underway REDWOOD CITY, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral...
-
REDWOOD SHORES, Calif., March 01, 2016 (GLOBE NEWSWIRE) -- Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced...
-
Full Year Revenue Grew 13% and Non-GAAP Net Revenue Grew 16% Year over Year Positive Adjusted EBITDA for the Fourth Quarter and Full Year Rex Jackson to Join the Company as Chief Financial...
-
Relypsa reports encouraging initial demand for VeltassaVeltassa added to CMS 2016 Formulary Reference File and agreements signed with Express Scripts and CVS Caremark, the two largest pharmacy...
-
REDWOOD CITY, Calif., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Cardica, Inc. (Nasdaq:CRDC) today announced financial results for its fiscal second quarter ended December 31, 2015. Cardica’s management...
-
REDWOOD CITY, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- BroadVision, Inc. (NASDAQ:BVSN), a leading provider of e-business and engagement management solutions, today reported financial results for...
-
REDWOOD CITY, Calif., Feb. 03, 2016 (GLOBE NEWSWIRE) -- iMedical Innovation Inc., dba Biotricity, a healthcare technology company dedicated to delivering innovative, medically relevant biometric...
-
EUREKA, Calif., Jan. 27, 2016 (GLOBE NEWSWIRE) -- REDWOOD CAPITAL BANCORP (OTCBB:RWCB), the only locally owned and operated community bank holding company in Humboldt County, announced unaudited...
-
TOPEKA, Kan., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Security Benefit Life Insurance Company (SBL), Topeka, KS is pleased to announce that it has expanded the underlying fund options available within the...
-
ASTRAZENECA ENHANCES LONG TERM GROWTH THROUGH ONCOLOGY INVESTMENT IN ACERTA PHARMA Transaction includes late-stage, potential best-in-class irreversible small molecule BTK inhibitor,...